Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Substance Use Disorder
100%
Psychiatric Disorders
100%
Methylphenidate
100%
Psychiatric Symptoms
33%
Dual Diagnosis
33%
PubMed Database
16%
Rate of Increase
16%
Impulsivity
16%
High Dose
16%
Central Nervous System Stimulants
16%
Adverse Effects
16%
Cardiovascular Events
16%
Addiction
16%
Conduct Disorder
16%
Search Strategy
16%
Persons with Mental Illness
16%
Psychosis
16%
Inclusion Criteria
16%
Vulnerable Populations
16%
Dependence Effect
16%
Non-oral
16%
Concerta
16%
Oral Route
16%
Personality Disorders
16%
Route of Administration
16%
Cardiovascular Issues
16%
Cannabis Use
16%
Individual Personality
16%
Ritalin
16%
Psychological Effects
16%
Substance Abuse
16%
Cocaine Use Disorder
16%
Adverse Complications
16%
Mental Health
16%
Risk Factors
16%
Adverse Events
16%
Abuse Patterns
16%
Potential Risk Factors
16%
Prescription Drug Monitoring Program
16%
PRISMA Guidelines
16%
Comorbid Conditions
16%
Therapeutic Approaches
16%
Major Depressive Disorder
16%
Co-occurring Disorders
16%
Prescription Stimulants
16%
Anxiety Disorders
16%
Attention Deficit Hyperactivity Disorder
16%
Scopus Database
16%
Alcohol Use Disorder
16%
Nicotine Use Disorder
16%
Gastrointestinal Events
16%
Prevalence of Abuse
16%
Adverse Outcomes
16%
Mood Disorders
16%
Snort
16%
Biochemistry, Genetics and Molecular Biology
Impulsiveness
100%
Vulnerable Population
100%
Drug Megadose
100%
Mental Health
100%
Cannabis Use
100%
Scopus
100%
Prevalence
100%
Medline
100%
Psychology
Psychiatric Disorder
100%
Methylphenidate
100%
Systematic Review
100%
Neurological System
16%
Substance Abuse
16%
Major Depression
16%
Conduct Disorder
16%
Impulsivity
16%
Psychological Effect
16%
Personality Disorder
16%
Alcohol Use Disorder
16%
Mental Health
16%
Anxiety Disorder
16%
Attention Deficit Hyperactivity Disorder
16%
Mood Disorder
16%
Pharmacology, Toxicology and Pharmaceutical Science
Methylphenidate
100%
Drug Dependence
100%
Diseases
50%
Personality Disorder
12%
Cannabis
12%
Mood Disorder
12%
Route of Administration
12%
Anxiety Disorder
12%
Adverse Event
12%
Adverse Outcome
12%
Conduct Disorder
12%
Stimulant
12%
Attention Deficit Disorder
12%
Major Depression
12%
Prevalence
12%
Neuroscience
Methylphenidate
100%
Mental Disorder
50%
Analeptic
33%
Substance Abuse
16%
Conduct Disorder
16%
Adverse Effect
16%
Impulsivity
16%
Cannabis
16%
Mood Disorder
16%
Personality Disorder
16%
Anxiety Disorder
16%
Attention Deficit Hyperactivity Disorder
16%
Major Depressive Disorder
16%